Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.

The clinical trial - named HEAL-COVID - also aims to cut the number of patients being readmitted to hospital with complications as a result of having COVID.

Read the original article here>